Jennifer L. Kelly

Vitamin D Insufficiency and Prognosis in Non-Hodgkin's Lymphoma

Matthew T. Drake, Matthew J. Maurer, Brian K. Link et al. · Journal of Clinical Oncology · 2010 · 206 citations · Full text

Medicine, Nutrition, Oncology +17

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma

Jonathan W. Friedberg, Julie M. Vose, Jennifer L. Kelly et al. · Blood · 2011 · 192 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny

Jennifer H. Anolik, Jonathan W. Friedberg, Bo Zheng et al. · Clinical Immunology · 2006 · 183 citations

Life Sciences, Hematology, Immunology +16

Phase II study of a TLR‐9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma

Jonathan W. Friedberg, Jennifer L. Kelly, Donna Neuberg et al. · British Journal of Haematology · 2009 · 80 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

Jennifer L. Kelly, Gilles Salles, Bryan Goldman et al. · Journal of Clinical Oncology · 2015 · 76 citations

Medicine, Immunology, Oncology +17